Activation of STING can induce downstream gene products and improve tumor immune microenvironment, the downstream type I IFNs can enhances the cytotoxic activity of immune cells such as macrophages, dendritic cells (DCs), B cells, and T cells against tumor cells (108). Here, STING1 is linked to neoplasm.